A Yellow Fever 17D Virus Replicon-Based Vaccine Platform for Emerging Coronaviruses

The tremendous global impact of the current SARS-CoV-2 pandemic, as well as other current and recent outbreaks of (re)emerging viruses, emphasize the need for fast-track development of effective vaccines. Yellow fever virus 17D (YF17D) is a live-attenuated virus vaccine with an impressive efficacy r...

Descripción completa

Detalles Bibliográficos
Autores principales: Oreshkova, Nadia, Myeni, Sebenzile K., Mishra, Niraj, Albulescu, Irina C., Dalebout, Tim J., Snijder, Eric J., Bredenbeek, Peter J., Dallmeier, Kai, Kikkert, Marjolein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704410/
https://www.ncbi.nlm.nih.gov/pubmed/34960238
http://dx.doi.org/10.3390/vaccines9121492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704410/
https://www.ncbi.nlm.nih.gov/pubmed/34960238
http://dx.doi.org/10.3390/vaccines9121492

Ejemplares similares